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Summary
Alkaline phosphatase (AP) activity is stage specific in
mouse embryos and may be associated with compaction
and separation of trophectoderm from inner cell mass in
preimplantation development. We previously sequenced
a cDNA and two mouse AP genes that could contribute
to the AP activity in embryos. Oligonucleotide primers
were constructed from the three sequences and used in
the reverse transcription-polymerase chain reaction
technique to establish that two of the three AP isozymes
are transcribed during preimplantation development.
The predominant transcript (E-AP) is from a gene
highly homologous to the human tissue-specific APs, but
different from the mouse intestinal AP. Tissue non-
specific (TN) AP also is transcribed, but there is
approximately 10 times less TN-AP than E-AP tran-
script. The TN-AP isozyme is the predominant tran-
script of 7 to 14 day embryos and primordial germ cells.
A switch in predominance from E-AP to TN-AP must
occur during early postimplantation development. This
study establishes a framework for experiments to
determine the functions of the two isozymes during
preimplantation development.
Key words: alkaline phosphatase, mouse embryo,
preimplantation, polymerase chain reaction, primordial
germ cells.
Introduction
The first morphogenetic event of mouse embryogenesis
is an epithelialization of blastomeres that begins at the
8-cell stage (Ducibella, 1977; Pratt et al. 1982).
Polarization of cell-surface and cytoplasmic com-
ponents is followed closely by compaction, the maxi-
mization of cell surface contacts and the formation of
intercellular junctions. Epithelialization accompanies
differentiation of mouse cells into the trophectoderm
and inner cell mass (ICM) of the blastocyst. There is no
indication that these events are controlled by maternal
mRNAs. Transition from maternal to embryonic
control in mouse embryos, when maternal mRNA is
degraded and transcription from the zygotic genome
begins, occurs at the 2-cell stage and precedes the
events of compaction (for review, see Schultz, 1986).
Cell polarity and position of a cell are important to its
fate (Rossant, 1977; Johnson and Ziomek, 1981;
Balakier and Pedersen, 1982; Ziomek and Johnson,
1982). Therefore interactions between cells or between
cells and the environment, and thus the cell surface
molecules modulating these interactions, are import-
ant.
Alkaline phosphatases (AP, orthophosphomonoes-
ter phosphohydrolase, EC 3.1.3.1) constitute a small
family of cell surface enzymes that may play a role in
morphogenetic or differentialve processes. In general,
the physiological functions of the alkaline phosphatases
are unknown. Their importance has been inferred by
their ubiquitous species expression, their stage and
tissue specificities in vertebrate development and their
association with active centers of differentiation or
morphogenesis. By histochemical staining, AP activity
appears at the late 2- or 4-cell stage of mouse embryos
and appears to be restricted to the ICM of late
blastocysts and primary ectoderm of pregastrulation
embryos (Mulnard and Huygens, 1978; Izquierdo et al.
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1980; Ziomek, unpublished results). There are foci of
high AP activity in postgastrulation embryos, including
primordial germ cells (Chiquoine, 1954; Mintz and
Russell, 1957).
w Most of what is known about the AP isozymes comes
from studies with human adult tissues (for reviews, see
Fishman, 1974; Sussman, 1984; MiMn, 1988; Harris,
1989). In man, the cDNAs and genomic sequences for
four isozymes have been determined, and they code for
the enzymes referred to as tissue non-specific or
liver/bone/kidney AP (TN-AP) and the tissue-specific
APs intestinal AP (I-AP), term placental AP (Pl-AP)
and testicular germ-cell AP (GC-AP). There is immu-
nological cross-reactivity between human I-AP, Pl-AP
and GC-AP, but no cross-reactivity between any of
these and the TN-AP form. The AP proteins are coded
for by mRNAs that are approximately 2.4kb long.
I-AP, Pl-AP and GC-AP are highly homologous (a
minimum of 90 % sequence identity at the amino acid
level), whereas TN-AP is only 57 % identical to I-AP at
the amino acid level. In mice, only two isozymes have
been previously distinguished by biochemical tech-
niques, one characteristic of the intestine and the other
of liver, bone, kidney and placenta (Goldstein et al.
1980). A separate placental form of the enzyme,
equivalent to human Pl-AP, does not appear to exist in
mice (Goldstein et al. 1980; Terao and Mintz, 1987).
Kim et al. (1989) suggested that multiple forms of AP
are expressed during mouse preimplantation develop-
ment, but they could not distinguish between secondary
processing differences and multiple genes. Lepire and
Ziomek (1989) identified an AP in preimplantation
mouse embryos with an activity profile similar to that of
human Pl-AP and mouse I-AP, although not identical
to either. They also reported that the preimplantation
form of AP cross-reacted immunologically with the
human Pl-AP and GC-AP isozymes. Although Lepire
and Ziomek did not detect a TN-AP isozyme in
preimplantation embryos, Merchant-Larios etal. (1985)
only found enzyme activity of the TN-AP form in
postimplantation embryonic tissues, including primor-
dial germ cells from day 7 to day 15. Mouse embryonal
carcinoma (EC) cells express an AP with an electro-
phoretic, inhibition and immunological pattern like that
of mouse TN-AP (Hass et al. 1979).
The findings reported above do not conclusively
establish which AP genes are transcribed during
development. The first step toward assigning a role to
these cell surface molecules during preimplantation
development is a definitive characterization of the gene
expression pattern of this small multi-gene family. We
previously sequenced a cDNA of an AP from mouse
Nulli SCC1 (nullipotent) EC cells (Hahnel and Schultz,
1989). This AP is in the TN-AP isozyme group by
comparison to the human sequences and is the same as
that expressed in mouse term placenta (Terao and
Mintz, 1987). We also have completed the sequences of
two mouse genomic AP clones with close homology to
human I-AP, Pl-AP and GC-AP (Manes et al. 1990).
Using the three sequences, we constructed oligonucleo-
tides and used the reverse transcription-polymerase
chain reaction (RT-PCR) technique to determine which
of the three isozymes is transcribed during early mouse
development and in other selected mouse cells includ-
ing primordial germ cells. We found that preimplan-
tation embryos do not express I-AP and do express TN-
AP. However, the predominant AP mRNA of pre-
implantation embryos (E-AP) is transcribed from a
third mouse AP gene similar to the germ cell AP of
human testis, although E-AP is not transcribed by
mouse primordial germ cells.
Materials and methods
Embryo recovery
Random-bred CD1 mice (Charles River Breeding Labora-
tories) were used throughout the study, except for the gel
analysis of AP activity. For these gels, CF1 females (Harlan
Sprague Dawley) mated to B6SJL/J males (Jackson Labora-
tory) were used due to their superior embryo yield per female
(Chatot et al. 1990). Procedures for superovulation and
recovery of oocytes and preimplantation embryos were as
described in Giebelhaus et al. (1983). Procedures for recovery
of postimplantation embryos (day 7.5 to 9.5) from naturally
mated females were as described in Hogan et al. (1986).
Isolation of primordial germ cells
Gonads with mesonephros were dissected from 12 to 14 day
CD1 fetuses using fine watchmaker's forceps in a large volume
of calcium- and magnesium-free phosphate-buffered saline
(CMF PBS). The gonads were separated from the mesoneph-
ros using glass needles and pooled (usually from a litter size of
10-12) regardless of sex. The tissues were washed briefly with
CMF PBS, followed by two transfers to 100^1 drops of
trypsin/pancreatin (0.5 %/2.5 %) with incubation at 37°C for
30min in the second drop. After incubation, an equal amount
of flushing medium-1 (Spindle, 1980) containing 10 % fetal
calf serum was added and the suspension was aspirated in and
out of a Gilson pipetteman with a yellow tip. The suspension
was put in a 15 ml centrifuge tube with 5 ml of L15 medium
containing serum and centrifuged at room temperature for
5min at 1000 revs min"1, the supernatant poured off and the
pellet resuspended in 5 ml of 0.025 % bovine serum albumin
in CMF PBS and centrifuged again as above. The cell pellet
was resuspended in 200 jil of 0.025 % BSA and loaded on top
of a 12 ml 0.5-10% BSA gradient in an inverted 12 ml sterile
plastic syringe fitted with silicon tubing for fraction collection.
The cells were allowed to separate for 3h at room
temperature, and lml fractions were collected from the
bottom. Fractions 1-6 were pooled and kept separate from
the pool of fractions 7-12. The two pools were centrifuged,
and the pellets stored at -20°C in 100 iA 4 M of guanidinium
thiocyanate containing 20 fig E. coli RNA as a carrier.
RNA, cDNA and DNA preparation
RNA was extracted from pools of 100 to 300 preimplantation
embryos in the presence of 5-10 ^g of E. coli ribosomal RNA
(Boehringer-Mannheim), as described by Giebelhaus et al.
(1983). Embryos in 50 /il of buffer (0.2 M NaCl, lmM EDTA,
25 mM Tris, pH7.4) were vortexed with an equal volume of
phenol, and phases were separated by centrifugation. The
aqueous phase was re-extracted with chloroform, recovered
after centrifugation and precipitated in ethanol. RNA pellets
were dissolved in 3 /d of sterile distilled water and the entire
sample was reverse transcribed (see below).
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To extract RNA from 7.5 to 9.5 day embryos, pools of 15
embryos at each stage were homogenized in 100 to 200 jd of
cold buffer composed of 0.2 M NaCl, 0.05 M Tris-HCl, pH 7.2,
0.005 M MgCl2 and 0.5 % Triton X-100. The homogenate was
centrifuged to pellet nuclei and cell debris and the resultant
supernatant adjusted to 10 mM EDTA and 1% sodium
dodecyl sulfate (SDS) by addition of appropriate amounts of
concentrated stock solutions. The supernatant was extracted
two times with an organic phase of phenolxhloroform (1:1)
and the resultant aqueous phase was extracted a final time
with chloroform:isoamyl alcohol (24:1). Following centrifu-
gation to separate phases, RNA was precipitated from the
aqueous phase by addition of 2 volumes of cold absolute
ethanol and storage at —20°C overnight. The RNA pellet was
collected by centrifugation, washed with 80% ethanol and
dissolved in water for use in the RT-PCR procedure.
Genital ridges, EC cells and adult tissues were dissolved in
4M guanidinium thiocyanate, 0.1M Tris (pH7.5), 1%
2-mercaptoethanol and 0.5 % sodium lauryl sarcosinate
(MacDonald et al. 1987). RNA was separated from protein
and DNA by centrifugation through cesium trifluoroacetate
(1.51 gml"1) according to the manufacturer's protocol (Phar-
macia).
RNA was reverse transcribed at 43 °C for 60min in a final
volume of 20 [A containing 500 /an each dNTP, 100/igml"1
oligo (dT), 30i.u. AMV reverse transcriptase (Molecular
Genetics), li.u./il"1 human placental ribonuclease inhibitor
(RNAguard, Pharmacia), 50 mM Tris (pH8.3), 10 mM MgCl2
and 10 mM dithiothreitol (Hagen et al. 1988). The reaction
volume was increased to 100 /A with 10 mM Tris (pH 7.5), 1 mM
EDTA and extracted once each with an equal volume of
phenol and chloroform and precipitated in ethanol. The pellet
was dissolved in 30^1 of 2mM Tris (pH8.2).
Mouse genomic DNA was extracted from tail tissue
according to the method of Hogan et al. (1986).
Primer pairs
The mouse TN-AP primer pair was constructed from the
sequence of a cDNA in a Nulli SCC1 EC cell library (Hahnel
and Schultz, 1989). The 5' primer is identical to nucleotides
1283 through 1302 (20-mer), and the 3' primer is the reverse
complement of nucleotides 1591 through 1612 (22-mer). The
E-AP and I-AP primers were derived from the corresponding
genomic sequences (Manes etal. 1990). The 5' E-AP primer is
identical to nucleotides 2464 through 2484 (21-mer) of the
E-AP gene and anneals within exon IX; its 3' partner is the
reverse complement of nucleotides 3082 through 3101 (20-
mer) and primes within exon XI. The 5' I-AP primer is the
same as nucleotides 1624 through 1644 (21-mer) of the I-AP
gene and anneals within exon VI, and the 3' primer is the
reverse complement of nucleotides 2281 through 2302 (22-
mer) and primes within exon IX. These oligonucleotides were
prepared by the Regional DNA Synthesis Laboratory,
Department of Medical Biochemistry, University of Calgary,
Calgary, Alberta, Canada. The 5' c-kit primer is the same as
nucleotides 4774 through 4796 of the published sequence (Qiu
et al. 1988), and the 3' primer is the reverse complement of
nucleotides 4954 through 4976. The c-kit primers were
prepared by the Biomolecular Resource Center, University of
California, San Francisco.
PCR
PCR was performed as described by Saiki et al. (1988) and
Rappolee et al. (1988, 1989). One-tenth (3^1 or material
equivalent to approximately 10-30 embryos) of a reverse
transcription reaction (or 600 ng genomic DNA) was ampli-
fied in a final volume of 50/d (100 [d for genomic DNA)
containing 10 mM Tris (pH8.4), 50 mM KG, 5/xg nuclease-free
BSA, lmM MgCl2 (2mM for genomic DNA), ljiM each
sequence-specific primer, 1/JM each dNTP and 1 U per 50//I
Thermits aquaticus (Taq) DNA polymerase (Amplitaq, U.S.
Biochemical). The mixture was overlaid with mineral oil,
presoaked at 94°C for 3 min and subjected to 25 to 60 cycles of
amplification in a DNA thermal cycler (Perkin-Elmer Cetus).
Each cycle consisted of denaturation at 94°C, cooling to 55 °C
over 2 min (to anneal the primers) and extension at 72 °C.
Products of the PCR reaction (one-fifth reaction volume)
were resolved electrophoretically on 2 % agarose gels along
with a small molecular weight DNA ladder (pBR322 cut with
Hinfl), stained with ethidium bromide and photographed
with Polaroid 52 film.
To quantify PCR product, amplification was performed as
above except that 0.8/iCi a- P-dCTP (SOOOCimmol"1, ICN)
was added to each reaction in the first trial and 2/iCi per
reaction in the second trial. One-fifth of the reaction product
was separated and stained in 2 % agarose as above, the bands
were excised, and radioactivity was determined in liquid
scintillant (Econofluor-2, NEN). Background levels were
determined from agarose slices removed from the area above
the bands.
For restriction enzyme analysis, amplified PCR products
were ethanol precipitated and resuspended in the appropriate
restriction enzyme buffer. Digested and undigested PCR
products were separated on 6% nondenaturing acrylamide
gels and stained with ethidium bromide or electrophoretically
transferred to nylon membranes (Nytran, Schleicher and
Schuell). A Southern blot of putative TN-AP PCR product
from blastocysts was hybridized to an RNA synthesized from
the 2.4kb TN-AP cDNA (Hahnel and Schultz, 1989) with T7
RNA polymerase (Pharmacia) in the presence of <*-35S-UTP
(ISSOCimmol"1, NEN). Conditions for hybridization and
posthybridization washes were as described previously (Hah-
nel et al. 1986) except that the SDS concentration was 0.75 %
and dextran sulfate was omitted.
Gel analysis of AP activity
Various stage embryos were collected in 10^1 of Hanks'
Balanced Salt solution containing 0.66 mg ml"1 polyvinylpyr-
rolidone (Sigma) and frozen at — 70 °C. All samples were
mixed with an equal volume of 2x sample buffer (0.125 M
Tris, 4.6 % SDS, 10% glycerol and 5% i3-mercaptoethanol).
Non-boiled samples of 250 embryos per lane, human placental
AP (hPLAP) and bovine kidney AP (TN-AP) (Sigma) were
loaded onto duplicate 7.5% SDS-polyacrylamide mini slab
gels (0.4 % SDS). After electrophoresis, one gel served as the
control, while the other was incubated for 1 h at room
temperature in lmM levamisole (Sigma). Both gels were
stained overnight for AP activity with the Promega Protoblot
AP detection system (Promega Blotec) in the absence
(control) and presence of lmM levamisole (inhibited). The
AP stain buffer contained 0.1M Tris, 0 .1M sodium chloride,
and 0.005 M MgCl2 at pH9.5. The staining solution contained
0.33 mg nitro blue tetrazolium (NBT) and 0.165 mg
5-bromo-4-chloro-3-indolyl-phosphate (BCIP) per ml of AP
stain buffer.
Results
Design of oligonucleotide primer pairs
We designed oligonucleotide primer pairs that bracket
target sequences specific for each of the three mRNAs
(cDNAs) that encode mouse APs (Fig. 1). There are 6
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TESUE NON-SPECIFC AP TARGET SEQUENCE
CTCCATACACCCCCCCeCCC 20
3 '
I I(700bp)
G<rK7raKrrcc
CCC<XATCCTATATQ3TAACGCGCCTOGCTACAJU3GTOaTOaACOOTaAACa43aA 130
J I ( 5 0 0 b j > )
AAATCTCTCCATOCTAGArrACOTrCAaiACAACTACCiGGCCCAarCCBCTOTr 119
CCCCTacaCCATGJU3ACCCACGCTGCJU3AJU3ACOraacaaTCriTOCCAAOaaCC 240
Hha I A Ap> I *
CCCCTATOCCTCCTCCMTgCCCCCAACCTTgACC
3 ' JTUJttR
EMBRYONIC AP TARGET SEQUENCE
COCACCAGTCAGCAGCACACG 21
3 ' PKIHEK
ATGATCCTTCTCACTGCCCACCACTCTCACCT
I I(113bp)
TACACAC 76
1 
TCTIT«MCTO^rCCCTTCAAGGCT5AC«
CTTTACCTCGATACTATACCCCAACCGTCCTGGTTACAAOCTCCATAATO5CCCC 186
Ava I I * Alu I * Km II *
I I(»7bp)
COGGCTOATCTCACTGACGAAGAGACCAGCAACCCCACGTACCACCACCACCCCT 2 61
S t u I A
ffrCTTACCCCTirnarrCAGACACCCACACCCCCCACGACGTCCCAATATTCCCCa: 296
S a p I L
TGCCCCACACGCCCACCTGCTCCACGGAaTTCACOAaCACAACTACATCCCGCAC 351
CCCCTCCTCCCCAQACCACTGCACTgACCCCQGQC
3' PRUIER
INTESTINAL AP TARGET SEQUENCE
CCTCOAACCCCAgACCCCCAS 21
3' PRIHEH
J I ( 1 2 9 b p )
CATTCAGJUUHWXawa^TCCCrCACTGACATACCTCATCCCCCTCTTTOACCCT 186
B u HI '
241
296
331
Sim
l l ( 7 3 b p )
GCGCTCACTGAGGCTCTGATCTTCGAi
Fig. 1. PCR target sequences from three mouse AP
cDNAs. Primer sequences are underlined; arrows indicate
intron (I) sites in the genomic sequences, and the intron
size is in brackets; arrowheads indicate location of
diagnostic restriction endonuclease cleavage sites. The
mouse TN-AP genomic sequence was assumed to have the
same introns as the human gene (Weiss et al. 1988).
to 15 mismatches between primer sequences and their
homologues in the other cDNAs. The primers for one
cDNA did not bind to cDNA from the other two
isozymes under our annealing conditions (55 °C). If the
AP mRNA sequenced from EC cells (tissue non-
specific, TN-AP) was present, then the appropriate
primer pair was expected to amplify a 330 bp piece of
DNA that would cut with the restriction endonucleases
Hhal and Apal. The primer pair constructed for the
first genomic sequence (called embryonic, E-AP, see
below) was designed to amplify a section of cDNA
438bp long that would cut with Ahall, Alul, Aval and
Sspl. Primers constructed for the second genomic
sequence (intestinal, I-AP) would amplify a 394bp
piece of cDNA that would cut with BamHl and Accl.
The RNA extraction technique that we used excludes
DNA, but the primer pairs also were selected to cross
intron-exon borders of the genomic sequences (arrows
in Fig. 1). Genomic DNA would produce a larger
product than the cDNA, allowing us to distinguish
between signal due to mRNA and signal due to
contaminating genomic DNA. We amplified mouse
genomic DNA using the three primer pairs (Fig. 2)).
All samples produced DNA of the expected size for the
genomic sequence. The smaller size band predicted by
mRNA (cDNA) sequence was not amplified in genomic
1636
TN
Fig. 2. Mouse genomic DNA amplified with three mouse
AP primer pairs. 600 ng of mouse genomic DNA was
amplified with primer pairs specific for tissue non-specific
AP (TN), embryonic AP (E) and intestinal AP (I), and the
DNA fragments resolved on a 2% agarose gel. Marker
DNA (pBR322 cleaved with Hinfl) is in the far left lane.
The expected fragment sizes (exons plus introns) were:
TN-AP, approximately 1530 bp (by analogy to the human
TN-AP genomic sequence); E-AP, 638bp; and I-AP,
679 bp.
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DNA samples. Likewise, the larger genomic target
sequences were not amplified in any of the RNA
preparations, indicating that they were, indeed, free of
contaminating DNA sequences (see Figs 3, 5 and 6). A
minor band of approximately 150 bp was detected after
amplification of DNA with the TN-AP primer pair. We
do not know the identity of this minor band, but it is not
of the correct size to be derived from either genomic
DNA or messenger RNA TN-AP sequences.
Expression of AP mRNAs and protein in
preimplantation embryos and selected tissues
The results of PCR amplification of cDNA from
preimplantation mouse embryos and selected adult
tissues are shown in Fig. 3. E-AP mRNA is present in
2-cell and 8-cell embryos and blastocysts, but not in
unfertilized eggs. Our PCR reactions used reverse-
transcribed RNA from roughly equivalent numbers of
embryos because total embryo mass and protein
content do not change greatly during the preimplan-
tation period (Schultz, 1986), and because the exact
number of cells in what is morphologically a blastocyst
E-AP TN-AP
varies. Moreover, within the blastocyst there is more
than one cell type that may transcribe AP mRNA. Since
we could have missed detecting mRNA in unfertilized
eggs because too few cells were extracted to be within
RT-PCR detection limits, we also amplified cDNA
from eight times the number of eggs (116) as 8-cell
embryos (14). E-AP mRNA still was not detected in
eggs in this experiment (data not shown).
TN-AP mRNA regularly was detected in 2-cell
embryos through blastocysts, although it took more
cycles to detect than the E-AP form in all but the
blastocyst stage. A TN-AP product was occasionally
amplified in unfertilized egg preparations and was the
only AP mRNA detected in extracts of whole 7.5, 8.5
and 9.5 day embryos by RT-PCR (data not shown).
I-AP mRNA was not present in preimplantation
embryos or nullipotent EC cells, but was the major
isozyme found in mouse intestinal RNA (thus I-AP).
The E-AP fragment was amplified in adult mouse testis
and intestine, but not in liver or nullipotent'EC cells.
TN-AP RNA was detected by PCR in EC cells, liver,
testis and intestine.
In each case, the size of the amplified DNA was as
I - AP
S06
-438 see
3 3 0
3 9 4
220-
154-
B
506-
E AP TN-AP I-AP
438
506-
3 3 0
154
3 9 4
Fig. 3. Expression of AP isozymes in embryonic and adult tissues. (A) RT-PCR results from mouse preimplantation
embryos. RNA from unfertilized eggs (E), 2-cell embryos (2), 8-cell embryos (8) and blastocysts (B) was reverse
transcribed and amplified by PCR with primers specific for three mouse AP cDNAs. Products were resolved on 2 %
agarose gels along with molecular weight markers. Size of the PCR product expected from the cDNA sequence of an AP
isozyme is indicated on the right of each gel. cDNA from 21 unfertilized eggs, 31 2-cell embryos, 17 8-cell embryos and 14
blastocysts was amplified by RT-PCR with the E-AP and I-AP primers. cDNA from 11 unfertilized eggs, 8 2-cell embryos,
11 8-cell embryos and 7 blastocysts was amplified by RT-PCR with the TN-AP primers. (B) RT-PCR results from mouse
cell and tissue types. RNA samples from Nulli SCC1 embryonal carcinoma cells (EC), liver (L), intestine (I) and testis (T)
were treated as described above.
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E AP TN AP I AP
506-
330-
-285
193-
137-
220-
154 -153
75
Fig. 4. Identification of AP PCR amplification products by restriction enzyme mapping. cDNA from 8-cell embryos was
amplified with the E-AP primer pair, cDNA from blastocysts with the TN-AP primer pair and cDNA from intestine with
the I-AP primer pair. The amplified product was cleaved with the indicated restriction enzymes, and the fragments
separated on 6 % non-denaturing polyacrylamide gels along with molecular weight markers. The PCR product from
amplification of an EC cell cDNA with TN-AP primers also was processed as above (EC), transferred to a nylon
membrane and hybridized at high stringency to the cDNA clone of mouse TN-AP (left lane of center panel).
expected from the isozyme nucleotide sequence.
Further proof of identity was established by restriction
enzyme digestion (Fig. 4). The PCR fragment amplified
with the TN-AP primers from blastocysts cut with Hhal
(and Apal, data not shown) as predicted. The fragment
also hybridized at high stringency to the original AP
cDNA clone from the EC cell library. The E-AP PCR
fragment from 8-cell embryos cut with four restriction
endonucleases giving the expected patterns, and the
I-AP from small intestine cut appropriately with
BamHl and Accl.
From the intensity of ethidium bromide staining on
gels, we consistently observed more E-AP product than
TN-AP product in preimplantation embryos. This
visual observation was confirmed by comparing
radioactively labeled PCR product from 2-cell, 8-cell
and blastocyst-stage embryos. DNA bands were excised
from agarose gels and radioactivity was determined by
liquid scintillation spectrometry (Table 1). TN-AP PCR
product from 2-celJ embryo cDNA was detectable only
after 40 cycles, whereas E-AP product was detectable
after 30 cycles. TN-AP product was 12 % of the total
AP product at 40 cycles (850 and 63OOctsmin~1 above
background for TN-AP and E-AP, respectively). At the
Table 1. Incorporation of32P-dCTP (ctsmin~1xl0~2) into AP cDNA by RT-PCR
PCR cycles
Primers
25
TN-AP E-AP
30
TN-AP E-AP
35 40
TN-AP E-AP TN-AP E-AP
cDNA source:
2-cell embryo
8-cell embryo
Blastocyst
Testis 8.1
(55%)
6.7
Nf
6.4
(21%)
6.7
(17%)
12.4
(48%)
7.6
24.0
33.3
13.4
N
10.0
(20%)
10.7
(13%)
23.2
(55%)
18.0
39.2
70.9
19.0
8.5
(12%)
14.8
(16%)
21.7
(16%)
57.3
(64%)
62.9
75.8
110.8
32.1
'Numbers in parentheses represent the percent of total AP PCR fragment incorporation represented by the TN-AP sequence.
| N , not detectable.
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8-cell stage, TN-AP product contributed on average
18% to the total AP product; 15% of blastocyst
product was amplified from TN-AP mRNA (cDNA).
7 % and 13 % of 8-cell stage and blastocyst AP product
was amplified from the TN-AP isozyme sequence when
a different set of RNA preparations was used (data not
shown). Both pairs of primers were tested on the same
embryo preparations and under the same conditions in
each experiment, but mRNAs can be differentially
extracted and reverse transcribed, and the primer pairs
may have different binding efficiencies. Even though
the percentages are approximations of the relative
abundance of the two types of mRNA in preimplan-
tation embryos, the results above suggest that 80 % to
90% of AP mRNA synthesized by preimplantation
mouse embryos is the E-AP isozyme.
To verify that, in addition to expression of both TN-
AP and E-AP genes as mRNA, the encoded proteins
were also expressed during preimplantation develop-
ment, 1-cell, 2-cell, 8-cell and blastocyst stage embryos
(250/lane) were run on SDS-polyacrylamide gels and
stained for AP activity in the presence and absence of
1 mM levamisole. The inhibitor levamisole is specific for
TN-AP (Borgers, 1973) and does not inhibit either
E-AP (Lepire and Ziomek, 1989) or human Pl-AP. As
seen in Fig. 5A, no significant AP activity was detected
in 1-cell embryos (a trace of activity is sometimes seen).
AP activity increased from the 2-cell to blastocyst stages
with the predominant form of AP (a doublet) running
ahead of human Pl-AP and showing resistance to
inhibition by levamisole (Fig. 5B). The doublet prob-
ably represents different levels of glycosylation of the
same base molecule as has been seen for many AP
isozymes and is not resolved in the 8-cell and blastocyst
lanes due to the overloading necessary to visualize the
third band of AP. This third minor form of AP, which
B
kd
200-
97.4-
69-
46-
30-
21.5-
a
1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8
Fig. 5. Gel analysis for AP activity. SDS-polyacrylamide
gels stained for AP activity in the absence (A) and
presence (B) of the TN-AP inhibitor, levamisole (lmM).
Lane 1, human Pl-AP; lane 3, 1-cell embryos; lane 4, 2-cell
embryos; lane 5, 8-cell embryos; lane 6, blastocysts; and
lane 8, bovine kidney AP. Lanes 2 and 7 are empty.
Positions of the molecular weight markers are indicated.
Arrowheads indicate the AP bands that disappear upon
levamisole treatment.
migrated more slowly than the doublet, was faint at the
8-cell stage and increased in the blastocyst. It was
sensitive to levamisole, as was the predominant slower-
migrating band of bovine kidney AP and represents the
expression of TN-AP in the preimplantation mouse
embryo. It therefore appears that both the E-AP and
TN-AP mRNAs are translated into protein during
preimplantation development and that the relative
abundance of each isozyme reflects the deduced relative
abundance of their respective mRNAs.
Expression of AP mRNA in primordial germ cells
Mouse primordial germ cells (PGC) are one of the few
cell types in day 10-14 embryos that histochemically
stain for AP activity (Chiquoine, 1954; Mintz and
Russell, 1957), and the only cell type to stain for AP
activity in genital ridges of day 12-14 embryos.
Although Merchant-Larios etal. (1985) showed that the
AP activity of PGC was of the TN-AP type using
specific inhibitors, we found that preimplantation
embryos and testicular cells contained E-AP mRNA.
Therefore, we used RT-PCR to determine which of the
three AP mRNAs are transcribed by PGC. RNA from
genital ridges of day 12 and day 13 embryos and gonads
from day 14 embryos were screened by the RT-PCR
procedure with the three AP primer pairs (Fig. 6A;
I-AP not shown). We determined that mouse PGC
transcribe TN-AP but not E-AP or I-AP. Cells from day
12 to 14 gonads also were separated on gradients into
two cell populations. The two fractions were analyzed
by RT-PCR with the AP primer pairs and with a primer
pair for the oncogene c-kit, a gene presumed to be
expressed by germ cells (Mintz and Russell, 1957;
Geissler et al. 1988; Nocka et al. 1989). Fig. 6B shows
that TN-AP is expressed in the cell fraction with c-kit
activity. No PCR amplification products were observed
in this fraction with E-AP or I-AP primer pairs.
Discussion
At least three AP genes are expressed in mice, two of
which are expressed by preimplantation mouse em-
bryos (see Table 2). The major AP mRNA of pre-
implantation embryos (E-AP) has close homology to
mouse I-AP, but is encoded by a distinct gene (Manes et
al. 1990). E-AP is not transcribed or translated in
unfertilized eggs but is detected in 2-cell stage embryos
when the zygotic genome becomes active and is
continuously transcribed and translated through the
blastocyst stage. Our results indicate that E-AP is not
the major AP mRNA of post-gastrulation embryos, nor
is it the isozyme expressed by migrating primordial
germ cells, although we cannot exclude the possibility
that a minor cell population transcribes E-AP in 7.5 to
9.5 day embryos. The temporal pattern of transcription
and translation of E-AP correlates with the time that
AP activity can be detected by histochemical staining in
preimplantation embryos (Mulnard and Huygens, 1978;
Izquierdo et al. 1980). We do not know yet whether all
cells of preimplantation embryos transcribe E-AP, but
562 A. C. Hahnel and others
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Table 2. Summary of AP gene expression in mouse
embryos and tissues
1 2 3 4 1 2 3 4
C-KIT
-330
203
Fig. 6. AP expression in mouse PGC. (A) RT-PCR
products from mouse genital ridge RNA were derived as
described in the legend to Fig. 3. Lane 1, 12-day genital
ridges; lane 2, 13 day genital ridges; lane 3, 14 day gonads;
lane 4, 14 day kidney. (B) RT-PCR products from two
gonadal cell populations. Cells from 12 to 14 day gonads
were separated into two cell populations and analyzed by
RT-PCR with the TN-AP primer pair and a primer pair
specific for mRNA from the oncogene c-kit. Lane 1 is cell
fraction 1, and lane 2 is cell fraction 2 amplified with the
TN-AP primer pair; lane 4 is cell fraction 1, and lane 5 is
cell fraction 2 amplified with the c-kit primer pair; lane 3 is
empty.
histochemical and immunohistochemical studies
suggest that AP protein is restricted to the ICM of late
blastocysts (Ziomek et al. 1990).
The second AP gene transcribed and translated by
mouse embryos is the one encoding the TN-AP
isozyme. TN-AP is the major isozyme transcribed by
7.5, 8.5 and 9.5 day embryos and also is expressed by
PGC, EC cells and placenta. At the level of transcrip-
tion, it constitutes less than 20 % of the total AP mRNA
during preimplantation development. The relatively
low abundance of TN-AP mRNA compared to E-AP
mRNA probably accounts for failure to detect this gene
product at the enzymatic level in previous studies.
TN-AP and E-AP mRNAs are transcribed in adult
mouse testis. A study with rat testis suggested that only
the TN-AP isozyme was synthesized (Kornblatt et al.
1983); however, the general consensus from human
studies is that both the TN-AP and GC-AP isozymes are
active in adult testis (Chang et al. 1980; Goldstein et al.
1982; Millan et al. 1982; Hustin et al. 1987; Milten and
Manes, 1988). We found that E-AP mRNA is only
slightly less abundant than the TN-AP isozyme
(Table 1), while less than 5% of total AP activity in
E-AP TN-AP I-AP
Embryonic cells
Unfertilized eggs — +/— -
2-cell stage + + -
8-cell stage + + -
Blastocyst + + -
7.5 day embryo — + —
8.5 day embryo — + —
9.5 day embryo — + —
PGC - + -
Nulli SCC1 EC - + -
Adult tissues
Testis + + ~
Liver — + • —
Intestine + +/— #
Thymus + + +
—, no detection by RT-PCR; +/—, occasional detection by RT-
PCR; + , presence of RT-PCR products.
human testicular extracts has been found to be due to
GC-AP (Chang et al. 1980). We do not know which
testicular cell types express each isozyme in the mouse.
Our results show that mouse testis expresses TN-AP
and E-AP, but that mouse PGC express only the TN-
AP isozyme.
The third isozyme examined was predominantly
transcribed in the intestine. I-AP mRNA was not
detected in preimplantation embryos, testis or PGC. It
was found, however, in thymus, along with mRNAs for
TN-AP and E-AP (data not shown). It is interesting
that E-AP mRNA also was found in intestine. Because
the mRNA was isolated from whole small intestine
(duodenum and upper jejunum) of adult mice, we
probably are not detecting the fetal form of the
intestinal isozyme (Vockley et al. 1984), and there are
other reports of two AP forms in adult intestine
(Garattini et al. 1985; Sussman et al. 1986).
E-AP and TN-AP are transcribed and translated by
early mouse embryos: E-AP is the predominant
isozyme of preimplantation embryos, and TN-AP is the
major isozyme of 7.5 to 14 day embryos. We do not
know when during early postimplantation development
the switch in isozyme predominance occurs, or whether
cells ever co-express the two isozymes. However, since
the sequences of the two isozymes now are known, and
either cDNA or genomic clones are available, it should
be possible to examine the role of each AP isozyme in
preimplantation development.
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